Recombinate - analogs
Components: Octocog alfa |
|||||||||
| Prices in pharmacies: — Instructions Recombinate | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Элластэнга Активный Глюкозамин ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 74% — Kogenate FS neutral [Octocog alfa and more 1Blood clotting Factor VIII]
- 65% — Hemlibra neutral [Emicizumab]
- 65% — Refacto AF neutral [Moroctocog alfa]
- 65% 69.2€ Octofactor neutral [Moroctocog alfa]
- 60% — Agemfil B neutral [Blood Clotting Factor IX]
- 59% 0.1€ Koate-HP neutral [Blood clotting Factor VIII]
- 59% — Иннонафактор neutral [Nonacog alfa]
- 56% — Octanine neutral [Blood Clotting Factor IX and more 1Proteine]
- 56% 35.6-136€ Octanat neutral [Blood clotting Factor VIII and more 1Proteine]
- 54% — Cryoprecipitate neutral [Blood clotting Factor VIII]
- 52% — Octavi neutral [Blood clotting Factor VIII and more 1Proteine]
- 49% — Gelaspon neutral [Formaldehyde]
- 49% — Koate-DVI neutral [Blood clotting Factor VIII]
- 49% — Kryobulin TIM 3 neutral [Blood clotting Factor VIII and more 1Alanine]
- 49% 73-200€ Immunate neutral [Blood clotting Factor VIII]
- 49% — Hemofil M neutral [Blood clotting Factor VIII]
- 46% — Konyne 80 neutral [Coagulation Factor II, VII, IX and X in combination [Prothrombin complex] and more 2Factor IX complex, Coagulation Factor VII]
- 45% 250€ Protromplex 600 neutral [Coagulation Factor II, VII, IX and X in combination [Prothrombin complex] and more 2Coagulation Factor VII, Factor IX complex]
- 45% — Eloctate neutral [Efmoroctocog alfa]
- 45% 162.8€ NovoSeven neutral [Eptacog alfa (activated)]
- 45% — Feiba neutral [Anti-inhibitor Coagulant Complex]
- 44% — Eptacog alfa (activated) neutral [Eptacog alfa (activated)]
- 44% 264.7-785€ Coagil-VII neutral [Eptacog alfa (activated)]
- 44% — АриоСэвен neutral [Eptacog alfa (activated)]
- 43% — Antihemophillic factor human-M (AHF-M) neutral [Blood clotting Factor VIII]
- 43% — Bebulin TIM 4 neutral [Blood Clotting Factor IX and more 2Proteine, Alanine]
- 43% — Emoclot D.I neutral [Blood clotting Factor VIII]
- 43% — Beriate neutral [Blood clotting Factor VIII]
- 43% — Haemate P neutral [Blood clotting Factor VIII]
- 43% — Эйтоплазм neutral [Blood clotting Factor VIII]
- 42% 35-137€ Octanine F (filtered) neutral [Blood Clotting Factor IX]
- 40% — Feracryl neutral [Ferric polyacrylate]
- 40% — Agemfil A neutral [Blood clotting Factor VIII]
- 40% — Железа полиакрилат neutral [Ferric polyacrylate]
- 39% — Wilfactin neutral [Willebrand factor]
- 39% 9.6-9.7€ Protamine sulfate neutral [Protamine sulfate]
- 39% — Trombinum neutral [Trombin]
- 39% — Протагем neutral [Protamine sulfate]
- 39% — Protamine sulfate solution for injections neutral [Protamine sulfate]
- 39% — Coaplex neutral [Coagulation Factor II, VII, IX and X in combination [Prothrombin complex] and more 2Coagulation Factor VII, Factor IX complex]
- 39% — Octaplex neutral [Coagulation Factor II, VII, IX and X in combination [Prothrombin complex] and more 2Coagulation Factor VII, Factor IX complex]
- 38% 135-190€ Nplate neutral [Romiplostim]
- 38% 230€ Стимплейт neutral [Romiplostim]
- 38% — Ромиплостим-ГЕРОФАРМ neutral [Romiplostim]
- 37% — Haemoctin neutral [Blood clotting Factor VIII]
- 36% — Протамин-Бинергия neutral [Protamine sulfate]
- 36% — Протамин neutral [Protamine sulfate]
- 36% — Protamine-Ferein neutral [Protamine sulfate]
- 34% 0.2€ Vicasol neutral [Menadione sodium bisulfite]
- 34% 0.6€ Vikasol-Darnitsa neutral [Menadione sodium bisulfite]
Learn more about the selection of analogues
▶
- The drug has «Recombinate» no complete analogues; 51 analog by action, the most similar - Octofactor (69.2€).
- Medical online service has selected the best substitutes for Recombinate based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Recombinate to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.